Early discontinuation of antidepressant treatment and suicide risk among persons aged 50 and over: A population-based register study

Journal of Affective Disorders

Volumn 119, Issue 1-3, 2009, Pages 194-199

  Erlangsen, Annette ^a,b   Agerbo, Esben ^a   Hawton, Keith ^c   Conwell, Yeates ^d  

^a AARHUS UNIVERSITY   (Denmark)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Aged; Antidepressants; Denmark; Non compliance; Suicide

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; DENMARK; FEMALE; GENDER; GROUPS BY AGE; HOSPITALIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL HOSPITAL; MOOD DISORDER; PENSION; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICAL MODEL; SUICIDE; TREATMENT WITHDRAWAL;

AGE FACTORS; ANTIDEPRESSIVE AGENTS; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SUICIDE;

EID: 70349982864     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.03.011     Document Type: Article

References (45)

1. BEF1A: Folketal pr.1.januar efter kommune/amt,civilstand,alder og køn [BEF1A: Population on Jan 1st by commune/county, civil status, age and sex]. Statistics Denmark. 2007. Statistics Denmark. 4-3-2007.
2. FOD5: Døde efter område,dødsårsag,alder og køn [FOD5: Deaths by area, cause of death, age and sex]. Statistics Denmark. 2007. Statistics Denmark. 4-3-2007.
3. Andersen P.K., Borgan O., Gill R.D., and Keiding N. Statistical Models Based on Counting Processes (1993), Springer-Verlag, New York
4. Andersen T.F., Madsen M., Jørgensen J., Mellemkjær L., and Olsen J.H. The Danish National Hospital Register. Dan. Med. Bull. 46 (1999) 263-268
5. Baldwin D.S., Cooper J.A., Huusom A.K., and Hindmarch I. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. Int. Clin. Psychopharmacol. 21 (2006) 159-169
6. Beyer J.L. Managing depression in geriatric populations. Ann. Clin. Psychiatry 19 (2007) 221-238
7. Blazer D.G. Depression in late life: review and commentary. J. Gerontol. A Biol. Sci. Med. Sci. 58 (2003) 249-265
8. Bogner H.R., Lin J.Y., and Morales K.H. Patterns of early adherence to the antidepressant citalopram among older primary care patients: the prospect study. Int. J. Psychiatry Med. 36 (2006) 103-119
9. Bruce M.L., Ten Have T.R., Reynolds C.F., Katz I.R., Schulberg H.C., Mulsant B.H., Brown G.K., McAvay G.J., Pearson J.L., and Alexopoulos G.S. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients. A randomized controlled trial. JAMA 291 (2004) 1081-1091
10. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis. 40 (1987) 373-383
11. Charney D.S., Reynolds III C.F., Lewis L., Lebowitz B.D., Sunderland T., Alexopoulos G.S., Blazer D.G., Katz I.R., Meyers B.S., Arean P.A., Borson S., Brown C., Bruce M.L., Callahan C.M., Charlson M.E., Conwell Y., Cuthbert B.N., Devanand D.P., Gibson M.J., Gottlieb G.L., Krishnan K.R., Laden S.K., Lyketsos C.G., Mulsant B.H., Niederehe G., Olin J.T., Oslin D.W., Pearson J., Persky T., Pollock B.G., Raetzman S., Reynolds M., Salzman C., Schulz R., Schwenk T.L., Scolnick E., Unutzer J., Weissman M.M., and Young R.C. Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch. Gen. Psychiatry 60 (2003) 664-672
12. Conwell Y., Duberstein P.R., Cox C., Herrmann J.H., Forbes N.T., and Caine E.D. Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am. J. Psychiatry 153 (1996) 1001-1008
13. Creed F. How do SSRIs help patients with irritable bowel syndrome?. Gut 55 (2006) 1065-1067
14. Erlangsen A., Bille-Brahe U., and Jeune B. Differences in suicide between the old and the oldest old. The Journals of Gerontology: Psychological Sciences and Social Sciences 58B (2003) 314-322
15. Erlangsen A., Canudas-Romo V., and Conwell Y. Increased use of antidepressants and decreasing suicide rates: a population-based study using Danish register data. J. Epidemiol. Community Health 62 (2008) 448-454
16. Eurostat. Statistics on persons in Denmark. A Register-based Statistical System (1995), Office for Official Publications of the European Communities, Luxembourg, Luxembourg
17. Frey R., Schreinzer D., Stimpfl T., Vycudilik W., Berzlanovich A., and Kasper S. Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991-1997: the favourable consequences of the increasing use of SSRIs. Eur. Neuropsychopharmacol. 10 (2000) 133-142
18. Giuliano F. 5-Hydroxytryptamine in premature ejaculation: opportunities for therapeutic intervention. Gut 30 (2007) 79-84
19. Givens J.L., Datto C.J., Ruckdeschel K., Knott K., Zubritsky C., Oslin D.W., Nyshadham S., Vanguri P., and Barg F.K. Older patients' aversion to antidepressants. A qualitative study. J. Gen. Intern. Med. 21 (2006) 146-151
20. Grunebaum M.F., Ellis S.P., Li S., Oquendo M.A., and Mann J.J. Antidepressants and suicide risk in the United States, 1985-1999. J. Clin. Psychiatry 65 (2004) 1456-1462
21. Hall W.D., Mant A., Mitchell P.B., Rendle V.A., Hickie I.B., and McManus P. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. Br. Med. J. 326 (2003) 1008-1011
22. Hansen D.G., Vach W., Rosholm J.U., Søndergaard J., Gram L.F., and Kragstrup J. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam. Pract. 21 (2004) 623-629
23. Hawton K. Assessment of suicide risk. Br. J. Psychiatry 150 (1987) 145-153
24. Isacsson G. Suicide prevention - a medical breakthrough?. Acta Psychiatr. Scand. 102 (2000) 113-117
25. Juurlink D.N., Mamdani M.M., Kopp A., and Redelmeier D.A. The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am. J. Psychiatry 163 (2006) 813-821
26. Knox K.L., Conwell Y., and Caine E.D. If suicide is a public health problem, what are we doing to prevent it?. Am. J. Public Health 94 (2004) 37-45
27. Kolmos L., and Bach E. Sources of error in registering suicide. Acta Psychiatr. Scand. Suppl. 76 (1987) 22-43
28. Lebowitz B.D., Pearson J.L., Schneider L.S., Reynolds C.F., Alexopoulos G.S., Bruce M.L., Conwell Y., Katz I.R., Meyers B.S., Morrison M.F., Mossey J., Niederehe G., and Parmelee P. Diagnosis and treatment of depression in late life. JAMA 278 (1997) 1186-1190
29. Morgan O.W.C., Griffiths C., and Majeed A. Association between mortality from suicide in England and antidepressant prescribing: an ecological study. BMC Public Health 4 (2004) 63-68
30. Munk-Jørgensen P., and Mortensen P.B. The Danish Psychiatric Central Register. Dan. Med. Bull. 44 (1997) 82-84
31. O'Connell H., Chin A.V., Cunningham C., and Lawlor B.A. Recent developments: suicide in older people. Br. Med. J. 329 (2004) 895-899
32. Pedersen C.B., Gøtzsche H., Møller J.Ø., and Mortensen P.B. The Danish Civil Registration System. Dan. Med. Bull. 53 (2006) 441-449
33. Rahme E., Dasgupta K., Turecki G., Nedjar H., and Galbaud du F.G. Risks of suicide and poisoning among elderly patients prescribed selective serotonin reuptake inhibitors: a retrospective cohort study. J. Clin. Psychiatry 69 (2008) 349-357
34. Robins J.M., Hernan M.A., and Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 11 (2000) 550-560
35. Rosenbaum P.R., and Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
36. Rosholm J.U., Andersen M., and Gram L.F. Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. Eur. J. Clin. Pharmacol. 56 (2001) 923-929
37. SAS system for SunOP. [9.1.3]. 2003. Cary, NC, USA, SAS Institute Inc.
38. Shah A. The relationship between suicide rates and age: an analysis of multinational data from the World Health Organization. Int. Psychogeriatr. 19 (2007) 1141-1152
39. Sindrup S.H., Bjerre U., and Dejgaard A. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin. Pharmacol. Ther. 52 (1992) 547-552
40. Steinman L.E., Frederick J.T., Prohaska T., Satariano W.A., Dornberg-Lee S., Fisher R., Graub P.B., Leith K., Presby K., Sharkey J., Snyder S., Turner D., Wilson N., Yagoda L., Unutzer J., and Snowden M. Recommendations for treating depression in community-based older adults. Am. J. Prev. Med. 33 (2007) 175-181
41. Stone T.E., Swanson C., and Feldman M.D. Venlafaxine discontinuation syndrome and suicidal ideation: a case series. J. Clin. Psychopharmacol. 27 (2007) 94-95
42. Vedsted P. [Gender differences in the use of health care system]. Ugeskr. Laeger 169 (2007) 2403-2408
43. Vergouwen A.C., Bakker A., Katon W.J., Verheij T.J., and Koerselman F. Improving adherence to antidepressants: a systematic review of interventions. J. Clin. Psychiatry 64 (2003) 1415-1420
44. Waern M., Rubenowitz E., and Wilhelmson K. Predictors of suicide in the old elderly. Gerontology 49 (2003) 328-334
45. Westenberg H.G., and Sandner C. Tolerability and safety of fluvoxamine and other antidepressants. Int. J. Clin. Pract. 60 (2006) 482-491